Accofil Accord
Description: A biosimilar biological medicine used to stimulate the production of white blood cells (neutrophils). It is a clear, colourless solution provided in a pre-filled syringe.
Share Now
Additional Information
Product Name: Accofil 30 MU/0.5 ml solution
Active Ingredient: Filgrastim (recombinant methionyl human granulocyte-colony stimulating factor)
Description: A biosimilar biological medicine used to stimulate the production of white blood cells (neutrophils). It is a clear, colourless solution provided in a pre-filled syringe.
Indication:
- Reducing the duration of neutropenia and incidence of febrile neutropenia in patients receiving cytotoxic chemotherapy.
- Reducing the duration of neutropenia in patients undergoing bone marrow transplantation.
- Mobilising peripheral blood progenitor cells (PBPC).
- Treating severe congenital, cyclic, or idiopathic neutropenia.
- Treating persistent neutropenia in patients with advanced HIV infection.
Strength: 30 MU (300 micrograms) in 0.5 ml
Business Partner: Accord Healthcare
Related Products
Related products
Disclaimer
Pharma Solutions is the master distributor for the listed products in Egypt. The products are either registered and approved by the respective local health authority or contracted by the MAH to supply to the end users on a named patient basis. Some products such as Orphan drugs, rare diseases medicines are imported based on special import permits and as per need of the Hospitals in compliance with full documentation.